Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
Common Shares [Member]
Shelf Offering
Common Shares [Member]
Additional Paid-in Capital [Member]
Shelf Offering
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Shelf Offering
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Shelf Offering
Accumulated Deficit [Member]
Convertible Preferred Stock [Member]
Shelf Offering
Convertible Preferred Stock [Member]
Shelf Offering
Total
Balance at Dec. 31, 2018   $ 0   $ 179,503,000   $ (45,000)   $ (175,640,000)   $ 0   $ 3,818,000
Balance (in shares) at Dec. 31, 2018   769,890               0    
Release of vested restricted common stock       (65,000)   0   0   $ 0   (65,000)
Release of vested restricted common stock (in shares)   6,193,000                    
Issuance of warrants for common stock   $ 0   0   0   0   $ 0   0
Issuance of warrants for common stock (in shares)   0               0    
Currency translation adjustment       0   (11,000)   0   $ 0   (11,000)
Net loss       0   0   (2,565,000)   0   (2,565,000)
Balance at Mar. 31, 2019       179,438,000   (56,000)   (178,205,000)   0   1,177,000
Balance (in shares) at Mar. 31, 2019   776,083                    
Balance at Dec. 31, 2018   $ 0   179,503,000   (45,000)   (175,640,000)   $ 0   3,818,000
Balance (in shares) at Dec. 31, 2018   769,890               0    
Warrant repricing                       0
Convertible/Accretion of preferred stock dividend       (16,000)   0   0   $ 16,000   (16,000)
Foreign currency translation adjustment                       (13,000)
Net loss                       (5,389,000)
Balance at Jun. 30, 2019       184,563,000   (58,000)   (181,029,000)   $ 477,000   3,476,000
Balance (in shares) at Jun. 30, 2019   987,946               250,000    
Balance at Mar. 31, 2019       179,438,000   (56,000)   (178,205,000)   $ 0   1,177,000
Balance (in shares) at Mar. 31, 2019   776,083                    
Issuance of common stock, net of shelf offering costs       4,664,000   0   0   0   4,664,000
Issuance of common stock, net of shelf offering costs (in shares)   203,786                    
Warrant repricing                       0
Foreign currency translation adjustment                       (2,000)
Proceeds from issuance of preferred stock and common stock warrants, net of issuance costs       200,000   0   0   $ 720,000   200,000
Proceeds from issuance of preferred stock and common stock warrants, net of issuance costs (in shares)                   250,000    
Fair value of derivative liability in connection with issuance of preferred stock       0   0   0   $ (216,000)   0
Issuance of warrants for common stock in connection with preferred stock offering       43,000   0   0   (43,000)   43,000
Issuance of common stock for services       234,000   0   0   0   234,000
Issuance of common stock for services (in shares)   8,077                    
Currency translation adjustment       0   (2,000)   0   0   (2,000)
Net loss       0   0   (2,824,000)   0   (2,824,000)
Balance at Jun. 30, 2019       184,563,000   (58,000)   (181,029,000)   $ 477,000   3,476,000
Balance (in shares) at Jun. 30, 2019   987,946               250,000    
Balance at Dec. 31, 2019   $ 0   188,320,000   (48,000)   (187,678,000)   $ 517,000   594,000 [1]
Balance (in shares) at Dec. 31, 2019   1,245,238               250,000    
Issuance of common stock, net of shelf offering costs   $ 0   725,000   0   0   $ 0   725,000
Issuance of common stock, net of shelf offering costs (in shares)   91,062               0    
Issuance of common stock in connection with notes payable   $ 0   4,000   0   0   $ 0   4,000
Issuance of common stock in connection with notes payable (in shares)   500               0    
Issuance of warrants in connection with convertible notes payable   $ 0   630,000   0   0   $ 0   630,000
Convertible/Accretion of preferred stock dividend   0   (20,000)   0   0   20,000   (20,000)
Stock-based compensation   $ 0   75,000   0   0   $ 0   75,000
Stock-based compensation (in shares)   2,000               0    
Restricted stock awards cancelled   $ 0   0   0   0   $ 0   0
Restricted stock awards cancelled (in shares)   (550)               0    
Release of vested restricted common stock   $ 0   0   0   0   $ 0   0
Release of vested restricted common stock (in shares)   353,000               0    
Net loss   $ 0   0   0   (2,680,000)   $ 0   (2,680,000)
Balance at Mar. 31, 2020   $ 0   189,734,000   (48,000)   (190,358,000)   $ 537,000   (672,000)
Balance (in shares) at Mar. 31, 2020   1,338,603               250,000    
Balance at Dec. 31, 2019   $ 0   188,320,000   (48,000)   (187,678,000)   $ 517,000   594,000 [1]
Balance (in shares) at Dec. 31, 2019   1,245,238               250,000    
Proceeds from the exercise of prefunded warrants and common stock warrants   $ 0   37,000   0   0   $ 0   37,000
Proceeds from the exercise of prefunded warrants and common stock warrants (in shares)   485,000               0    
Warrant repricing                       134,000
Convertible/Accretion of preferred stock dividend   $ 0   (20,000)   0   0   $ 20,000   (20,000)
Foreign currency translation adjustment                       0
Net loss                       (6,078,000)
Balance at Jun. 30, 2020   $ 1,000   205,430,000   0   (193,756,000)   $ 557,000   11,675,000
Balance (in shares) at Jun. 30, 2020   7,723,353               250,000    
Balance at Mar. 31, 2020   $ 0   189,734,000   (48,000)   (190,358,000)   $ 537,000   (672,000)
Balance (in shares) at Mar. 31, 2020   1,338,603               250,000    
Issuance of common stock, net of shelf offering costs $ 1,000   $ 9,957,000   $ 0   $ 0   $ 0   $ 9,958,000  
Issuance of common stock, net of shelf offering costs (in shares) 4,315,000               0      
Issuance of common stock, prefunded warrants and warrants, net of public offering costs   $ 0   5,515,000   0   0   $ 0   5,515,000
Issuance of common stock, prefunded warrants and warrants, net of public offering costs (in shares)   1,525,000               0    
Issuance of common stock in connection with settlements   $ 0   135,000   0   0   $ 0   135,000
Issuance of common stock in connection with settlements (in shares)   60,250               0    
Deemed dividend from warrant down-round provision   $ 0   (134,000)   0   0   $ 0   (134,000)
Warrant repricing   0   134,000   0   0   0   134,000
Stock-based compensation   $ 0   72,000   0   0   $ 0   72,000
Stock-based compensation (in shares)   2,000               0    
Restricted stock awards cancelled   $ 0   0   0   0   $ 0   0
Restricted stock awards cancelled (in shares)   (2,500)               0    
Foreign currency translation adjustment                       0
Issuance of common stock for warrant settlement   $ 0   135,000   0   0   $ 0   135,000
Issuance of common stock for warrant settlement (in shares)   60,250               0    
Gain on foreign currency translation from closure of subsidiary   $ 0   0   48,000   0   $ 0   48,000
Net loss   0   0   0   (3,398,000)   0   (3,398,000)
Balance at Jun. 30, 2020   $ 1,000   $ 205,430,000   $ 0   $ (193,756,000)   $ 557,000   $ 11,675,000
Balance (in shares) at Jun. 30, 2020   7,723,353               250,000    
[1] The condensed consolidated balance sheet as of December 31, 2019 was derived from the audited consolidated balance sheet as of that date.